PLAGL2 and colonic neoplasm: To explore the biological function of MYH9 in miR-214-3p/PLAGL2-regulated colon cancer progression, si-MYH9 was co-transfected with the Lv-miR-214-3p inhibitor into SW480 and HCT116 cells.